Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs TelePeptide

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and TelePeptide head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 223 · Grade C

TelePeptide

Visit TelePeptide Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 67 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make TelePeptide a bad call — it's best for readers choosing between monthly and prepaid compounded care who want explicit totals and will confirm the charge and refund agreement. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
36
Supply Reliability
95
83
Transparency
90
72
Access Breadth
93
56
Clinical Oversight
92
87
Track Record
88
78
CoreAge RxBrief Score 94 · 67TelePeptide

Price, coverage & the tracker

CoreAge RxTelePeptide
Brief Score94/100 (A)67/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$199/month for injections

Annual plan: $2,028 upfront, equivalent to $169/month.

Compounded medication, evaluation and shipping advertised as included; oral and microdose plans are separate.

Full price details

Compounded semaglutide injection advertised at $199/month; annual $2,028 upfront ($169/month equivalent); oral tablet is a separate plan; earlier listing: From $199/mo (starting dose, annual plan, compounded oral)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$249/month for injections

Annual plan: $2,568 upfront, equivalent to $214/month.

Compounded medication, evaluation and shipping advertised as included; oral and microdose plans are separate.

Full price details

Compounded tirzepatide injection advertised at $249/month; annual $2,568 upfront ($214/month equivalent); oral tablet is a separate plan; earlier listing: From $219/mo (starting dose, annual plan, compounded oral)

CoverageUS only; restrictions by state, confirmed at intakeAdvertises forty-eight states and DC, excluding Alaska and Mississippi; actual clinician and pharmacy eligibility still applies
Brand-name accessNot confirmedThe site expressly describes compounded programs and says it does not supply FDA-approved branded GLP-1 medications.
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

TelePeptide: Injectable monthly rates are $199 semaglutide and $249 tirzepatide; annual prepays are $2,028/$2,568. Oral and microdose plans have separate prices.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.